ChinaDaily Briefs

Daily Brief China: Public Financial, Raytron Technology , Sitoy Group, ENN Energy, SHEIN Global Holdings, Insilico Medicine, ASR Microelectronics, GigaDevice Semiconductor, Z.AI and more

By September 14, 2026 No Comments

In today’s briefing:

  • Merger Arb Mondays (14 Sep) – Public Financial, Skyworth, Changhong Jiahua, Z Fin, OFX, Cleanaway
  • STAR50 Sep 2026 Index Rebalance: Pre-Implementation Update
  • Sitoy : Value Trap or Not
  • ENN Energy (2688 HK): Things Are Not That Bad Without the Privatisation
  • SHEIN-W: Path to HS Indices, HK Connect and MS-China
  • INSILICO: Discovering the Fountain of Youth – You’re Not Getting Any Older !!
  • IPO Databook: ASR Microelectronics (HK) – Sep 2026
  • SHEIN IPO in Hong Kong: Latest Developments Affecting SHEIN, Temu, and AliExpress
  • GigaDevice (3986 HK): 2Q26, Taking Niche Market, Revenue Up by 230%
  • Aequitas ECM Weekly (14 September 2026)-Longsys, GCash, NSE, Ligent, Kingwong, Elice, Hosin, Z.AI



STAR50 Sep 2026 Index Rebalance: Pre-Implementation Update

By Ke Yan, CFA, FRM

  • STAR50 rebalance will be effective on 14 Sep 2026 before market open, with 5 ADDs and 5 DELETEs.
  • Four of the five ADDs gained at the post-announcement open, and all five then fell over the rest of the bridge. AVIC Chengdu UAS was the only DELETE to gain.
  • Historically, ADDs with a negative bridge averaged higher first-week returns than ADDs with a positive bridge. DELETEs with a negative bridge mostly kept falling in the first implementation week.

Sitoy : Value Trap or Not

By Punit Khanna

  • Stock trades at .3 x P/B, Cash on books is .38 cents per share, and Liquidation Value is .64 cents ( Net Current Assets less all liabilities is .64 cents.
  • Manufacturing business is the main business, and the company has blue-chip customers but not much pricing power.
  • The retail business has a chequered history, and the property value per share is 40 cents per share. Dividend Yield is 7%

Raising Money for Persons with Disabilities in Singapore

For your kind consideration

This report has been prepared by Vriddhi Consulting, founded by Punit and Debjani Khanna. A portion of the research was contributed by Shubham Khanna, an individual on the autism spectrum.  We are grateful to Smartkarma for providing a platform to share this research and amplify its impact.

All proceeds from the publication of this report will be donated to support people with disabilities in Singapore. If you find this report valuable, we invite you to support our campaign, “Raising Money for Persons with Disabilities in Singapore.” Every contribution directly benefits the Goh Chok Tong Enable Fund and qualifies for a 250% tax deduction for Singapore tax residents.

To contribute, please visit this URL. 


ENN Energy (2688 HK): Things Are Not That Bad Without the Privatisation

By Osbert Tang, CFA

  • ENN Energy (2688 HK)‘s 1H26 results demonstrated that, even without ENN Natural Gas (600803 CH)‘s privatisation, its fundamentals remain solid. 
  • Its gross margin decline has stabilised; with cost control initiatives, the FY26 earnings will stay healthy. Upside will come from improvement in the IE and smart home segments.
  • At 7.6x PER for FY26 and FY27, it is among the cheapest in the HSI and the gas utilities sector. Its P/B is now over 1SD below average. 

SHEIN-W: Path to HS Indices, HK Connect and MS-China

By Ke Yan, CFA, FRM

  • SHEIN listed on the HKEX Main Board on 1 Sep 2026, and we work out entry timing for HSCI, HSI, HSCEI, HS TECH, Stock Connect and MS-China.
  • HSIL confirmed the HSCI ADD after the 14 Sep 2026 close on 2 Sep, and a 2.3% FF holds MS-China and HSCEI entry until the 28 Feb 2027 lock-up expiry.
  • The December 2026 HSI review is the first cycle SHEIN can enter, and Southbound inclusion follows the WVR rule of six months plus 20 trading days on 31 Mar 2027.

INSILICO: Discovering the Fountain of Youth – You’re Not Getting Any Older !!

By David Mudd

  • Insilico Medicine (3696 HK) has risen since its 1H26 earnings announcement.  The company’s rentosertib drug reversed biological aging markers in its Phase IIa trial.
  • Rentosertib holds a singular distinction: it is the first end-to-end AI-discovered and AI-targeted drug to reach Phase III clinical development globally.
  • The China CDE permitted a direct jump from Phase IIa to Phase III based on efficacy data, an unusual regulatory concession.

IPO Databook: ASR Microelectronics (HK) – Sep 2026

By αSK IPO Databooks

  • ASR Microelectronics is a fabless semiconductor platform company, a market leader in cellular connectivity chips, ranking No. 1 globally in 2025.
  • ASR Microelectronics ranked No. 1 globally in cellular connectivity chip market by shipment volume in 2025 with 37.8% market share.
  • ASR Microelectronics reported a loss of RMB390,285 for 2025 and a profit of RMB84,244 for six months ended June 30, 2026.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


SHEIN IPO in Hong Kong: Latest Developments Affecting SHEIN, Temu, and AliExpress

By Daniel Hellberg

  • In this insight we update readers on new developments affecting SHEIN, Temu, AliExpress
  • New laws and ongoing investigations are likely to raise the cost of operating in the EU
  • We expect to hear about important legal milestones in the coming weeks – stay tuned!

GigaDevice (3986 HK): 2Q26, Taking Niche Market, Revenue Up by 230%

By Ming Lu

  • Revenue grew by 230% YoY in 2Q26 with gross margin up to 66% from 37% in 2Q25.
  • Chip giants pursue high-margin HBM and leave the niche DRAM market behind.
  • GigaDevice is the only fabless company that focus on niche DRAM.

Aequitas ECM Weekly (14 September 2026)-Longsys, GCash, NSE, Ligent, Kingwong, Elice, Hosin, Z.AI

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, Shenzhen Longsys Electronics (9976 HK) didn’t do much at listing and had one of the lowest institutional coverage ratios yet for large A/H listings.
  • On the placement front, the week wasn’t as busy but we did look at a few deals and upcoming lockups.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars